These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35216745)

  • 1. Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions.
    Kohli-Pamnani A; Zapata K; Gibson T; Kwittken PL
    Ann Allergy Asthma Immunol; 2022 Mar; 128(3):339. PubMed ID: 35216745
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
    Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis.
    Pienkowski MM; Pienkowski SM
    Ann Allergy Asthma Immunol; 2022 Jan; 128(1):101-103. PubMed ID: 34601091
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose.
    Gallagher MC; Haessler S; Pecoy-Whitcomb E; Bayuk J
    Allergy Asthma Proc; 2022 Jan; 43(1):37-39. PubMed ID: 34983708
    [No Abstract]   [Full Text] [Related]  

  • 6. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines.
    Szebeni J; Storm G; Ljubimova JY; Castells M; Phillips EJ; Turjeman K; Barenholz Y; Crommelin DJA; Dobrovolskaia MA
    Nat Nanotechnol; 2022 Apr; 17(4):337-346. PubMed ID: 35393599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
    Risma KA; Edwards KM; Hummell DS; Little FF; Norton AE; Stallings A; Wood RA; Milner JD
    J Allergy Clin Immunol; 2021 Jun; 147(6):2075-2082.e2. PubMed ID: 33857566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine.
    Maron JS; Conroy M; Naranbai V; Samarakoon U; Motazedi T; Farmer JR; Freeman E; Banerji A; Bartsch YC; Gregory DJ; Poznansky MC; Alter G; Blumenthal KG
    J Infect Dis; 2022 Sep; 226(7):1231-1236. PubMed ID: 35325158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic anaphylaxis after first dose of messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skin testing result.
    Pitlick MM; Park MA; Gonzalez-Estrada A; Chiarella SE
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):498-499. PubMed ID: 34343674
    [No Abstract]   [Full Text] [Related]  

  • 12. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama T; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
    [No Abstract]   [Full Text] [Related]  

  • 13. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 15. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.
    Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
    Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
    Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals.
    Collier AY; Yu J; McMahan K; Liu J; Atyeo C; Ansel JL; Fricker ZP; Pavlakis M; Curry MP; Jacob-Dolan C; Patel H; Sellers D; Barrett J; Rowe M; Ahmad K; Gompers A; Aguayo R; Chandrashekar A; Alter G; Hacker MR; Barouch DH
    J Infect Dis; 2022 Apr; 225(7):1124-1128. PubMed ID: 34792136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.
    Kelso JM
    Vaccine; 2021 Feb; 39(6):865-867. PubMed ID: 33441235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.